Moss, MD RB, Carleton, PhD F, Lollo, PhD CP, Carlo, PhD DJ. An open-label, randomized, single-dose, two-period, two-treatment crossover bioavailability study comparing 5 mg/0.5 mL of intramuscular naloxone hydrochloride to 2 mg/0.4 mL intramuscular naloxone hydrochloride autoinjector in healthy subjects. J of Opioid Management [Internet]. 2020 May 1 [cited 2024 Nov. 21];16(3):209-14. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/2747